StimCell Enegetics Inc. Stock Analysis STME
StimCell Energetics, Inc. is a biotech company, which engages in the discovery, development, and commercialization of therapeutic and non-therapeutic products. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2013-03-11. The firm's main focus is on continued research and development of its eBalance Technology and its eBalance Home System. eBalance is a non-invasive, fully automated microcurrent electrotherapy system administering pre-programmed algorithms through the epidermis at the touch of a button to help you gain optimal wellness and reduce pain. Its eBalance represents a monumental stride in the realm of medical technology designed to rejuvenate and re-energize the human body at a cellular level. The operation of eBalance is an intricate process of precision engineering and human biology.
Read More StimCell Enegetics Inc (STME) Chart
Key Statistics of StimCell Enegetics Inc (STME)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.31Volume
367.00P/E Ratio (TTM)
-52 Week Range
Market Cap
6.32MAvg. Volume
1710.78Dividend Yield
-Financial Metrics & Statements of StimCell Enegetics Inc (STME)
FAQ's for StimCell Enegetics Inc (STME)
- According to Musaffa’s Shariah screening methodology, StimCell Enegetics Inc (STME) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.